Literature DB >> 15189342

Brain antioxidant systems in human methamphetamine users.

Anna Mirecki1, Paul Fitzmaurice, Lee Ang, Kathryn S Kalasinsky, Frank J Peretti, Sally S Aiken, Dennis J Wickham, Allan Sherwin, José N Nobrega, Henry J Forman, Stephen J Kish.   

Abstract

Animal data suggest that the widely abused psychostimulant methamphetamine can damage brain dopamine neurones by causing dopamine-dependent oxidative stress; however, the relevance to human methamphetamine users is unclear. We measured levels of key antioxidant defences [reduced (GSH) and oxidized (GSSG) glutathione, six major GSH system enzymes, copper-zinc superoxide dismutase (CuZnSOD), uric acid] that are often altered after exposure to oxidative stress, in autopsied brain of human methamphetamine users and matched controls. Changes in the total (n = 20) methamphetamine group were limited to the dopamine-rich caudate (the striatal subdivision with the most severe dopamine loss) in which only activity of CuZnSOD (+ 14%) and GSSG levels (+ 58%) were changed. In the six methamphetamine users with severe (- 72 to - 97%) caudate dopamine loss, caudate CuZnSOD activity (+ 20%) and uric acid levels (+ 63%) were increased with a trend for decreased (- 35%) GSH concentration. Our data suggest that brain levels of many antioxidant systems are preserved in methamphetamine users and that GSH depletion, commonly observed during severe oxidative stress, might occur only with severe dopamine loss. Increased CuZnSOD and uric acid might reflect compensatory responses to oxidative stress. Future studies are necessary to establish whether these changes are associated with oxidative brain damage in human methamphetamine users.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15189342     DOI: 10.1111/j.1471-4159.2004.02434.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  25 in total

1.  Neuropsychological deficits in adolescent methamphetamine abusers.

Authors:  George King; Daniel Alicata; Christine Cloak; Linda Chang
Journal:  Psychopharmacology (Berl)       Date:  2010-07-17       Impact factor: 4.530

2.  Increase in clusterin-containing follicles in the adenohypophysis of drug abusers.

Authors:  Takaki Ishikawa; Bao-Li Zhu; Satoru Miyaishi; Hideo Ishizu; Hitoshi Maeda
Journal:  Int J Legal Med       Date:  2006-11-18       Impact factor: 2.686

3.  Brain levels of neuropeptides in human chronic methamphetamine users.

Authors:  Paul S Frankel; Mario E Alburges; Lloyd Bush; Glen R Hanson; Stephen J Kish
Journal:  Neuropharmacology       Date:  2007-06-28       Impact factor: 5.250

Review 4.  Glutathione and redox signaling in substance abuse.

Authors:  Joachim D Uys; Patrick J Mulholland; Danyelle M Townsend
Journal:  Biomed Pharmacother       Date:  2014-06-24       Impact factor: 6.529

Review 5.  Amphetamine toxicities: classical and emerging mechanisms.

Authors:  Bryan K Yamamoto; Anna Moszczynska; Gary A Gudelsky
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

Review 6.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

Review 7.  Role of Mitochondria in Methamphetamine-Induced Dopaminergic Neurotoxicity: Involvement in Oxidative Stress, Neuroinflammation, and Pro-apoptosis-A Review.

Authors:  Eun-Joo Shin; Hai-Quyen Tran; Phuong-Tram Nguyen; Ji Hoon Jeong; Seung-Yeol Nah; Choon-Gon Jang; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Neurochem Res       Date:  2017-06-07       Impact factor: 3.996

8.  Psychiatric symptoms and HPA axis function in adolescent methamphetamine users.

Authors:  George King; Daniel Alicata; Christine Cloak; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-01       Impact factor: 4.147

9.  Methamphetamine-induced locomotor changes are dependent on age, dose and genotype.

Authors:  Renee L Good; Richard A Radcliffe
Journal:  Pharmacol Biochem Behav       Date:  2010-12-14       Impact factor: 3.533

10.  Methamphetamine-Induced Brain Injury and Alcohol Drinking.

Authors:  Amanda L Blaker; Bryan K Yamamoto
Journal:  J Neuroimmune Pharmacol       Date:  2017-08-30       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.